BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025
Rhea-AI Summary
BillionToOne (NASDAQ: BLLN) will release financial results for the third quarter ended September 30, 2025 after market close on Tuesday, December 9, 2025. The company will host a conference call to discuss results at 1:30 PM PT / 4:30 PM ET the same day.
Investors must register to participate in the call before the start time. A live and archived webcast will be available on the company’s Events page at https://investors.billiontoone.com/.
Positive
- None.
Negative
- None.
News Market Reaction – BLLN
In the Dec 2 session, BLLN gained 1.66%, reflecting a mild positive market reaction. Argus tracked a trough of -8.0% from its starting point during tracking. Our momentum scanner triggered 17 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 09 | Board appointment | Positive | +4.7% | New audit committee chair added, reinforcing financial oversight and governance. |
| Dec 09 | Earnings results | Positive | +4.7% | Strong Q3 2025 revenue growth, margin expansion and positive net income. |
| Dec 02 | Earnings date notice | Neutral | +1.7% | Announcement of Q3 2025 results release date and conference call details. |
| Nov 07 | IPO closing | Positive | +2.2% | Closing of upsized IPO and full exercise of underwriters’ option. |
| Nov 06 | IPO announcement | Positive | -8.2% | Law firm announcement of BillionToOne’s upsized IPO and listing details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has mostly seen positive price reactions, with one notable negative move around an IPO-related announcement.
Over the last few months, BillionToOne has moved from IPO milestones to strong operating performance. The IPO in early November 2025 raised substantial capital, followed by Q3 2025 results showing rapid revenue growth and improved profitability. An audit committee chair appointment on Dec 09 highlighted governance build-out. A prior earnings date notice on Dec 02 also drew a modestly positive reaction, framing the current earnings-date release within a pattern of constructive corporate updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for third quarter ended September 30, 2025 after the market close on Tuesday, December 9, 2025. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.
To participate in the conference call, please register here before the 1:30pm Pacific Time / 4:30pm Eastern Time start. A live and archived webcast will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.
About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level.
Investor Contact
ir@billiontoone.com
Media Contact
billiontoone@moxiegrouppr.com
